trial · primary record
Dose-escalation study of epoprostenol as adjunct anticoagulation in ECMO
ECMO
| Phase | Phase 1, Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 44 |
| Primary completion | 2028-08 |
| Primary endpoint | Safety and Maximum Tolerated Dose |
| Registry ID | NCT07837869 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-02T15:44:54.912Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07837869
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.